{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:05:30Z","timestamp":1793106330199,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.prp.2023.154481","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T02:29:45Z","timestamp":1682389785000},"page":"154481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["HDAC1 mediates epithelial\u2013mesenchymal transition and promotes cancer cell invasion in glioblastoma"],"prefix":"10.1016","volume":"246","author":[{"given":"Zhe","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongdong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0026-6680","authenticated-orcid":false,"given":"Jun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2023.154481_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pharmthera.2015.05.005","article-title":"Glioblastoma multiforme: pathogenesis and treatment","volume":"152","author":"Alifieris","year":"2015","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.prp.2023.154481_bib2","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006\u20132010","volume":"15 Suppl. 2","author":"Ostrom","year":"2013","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.prp.2023.154481_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14041092","article-title":"Glioblastoma microenvironment and cellular interactions","volume":"14","author":"Crivii","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2023.154481_bib4","doi-asserted-by":"crossref","first-page":"n1560","DOI":"10.1136\/bmj.n1560","article-title":"Glioblastoma: clinical presentation, diagnosis, and management","volume":"374","author":"McKinnon","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.prp.2023.154481_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131670","article-title":"A potential role for the inhibition of PI3K signaling in glioblastoma therapy","volume":"10","author":"Str\u00f6bele","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2023.154481_bib6","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.radonc.2018.09.014","article-title":"MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties","volume":"129","author":"Lin","year":"2018","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.prp.2023.154481_bib7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12929-018-0464-y","article-title":"IL-8\/CXCR1\/2 signalling promotes tumor cell proliferation, invasion and vascular mimicry in glioblastoma","volume":"25","author":"Sharma","year":"2018","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.prp.2023.154481_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21061932","article-title":"Tumor cell invasion in glioblastoma","volume":"21","author":"Vollmann-Zwerenz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2023.154481_bib9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.prp.2023.154481_bib10","first-page":"371","article-title":"Chromatin immunoprecipitation (ChiP) protocol for the analysis of gene regulation by histone modifications in Agave angustifolia haw","volume":"2018","author":"Us-Camas","year":"1815","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.prp.2023.154481_bib11","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1096\/fj.14-250654","article-title":"Overexpression of histone deacetylases in cancer cells is controlled by interplay of transcription factors and epigenetic modulators","volume":"28","author":"Yang","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.prp.2023.154481_bib12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s13046-021-02135-x","article-title":"Differential gene expression-based connectivity mapping identified novel drug candidate and improved temozolomide efficacy for glioblastoma","volume":"40","author":"Vengoji","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.prp.2023.154481_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13046-022-02305-5","article-title":"miR-3189-targeted GLUT3 repression by HDAC2 knockdown inhibits glioblastoma tumorigenesis through regulating glucose metabolism and proliferation","volume":"41","author":"Kwak","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.prp.2023.154481_bib14","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.18632\/aging.204190","article-title":"MBD1\/HDAC3-miR-5701-FGFR2 axis promotes the development of gastric cancer","volume":"14","author":"Zhao","year":"2022","journal-title":"Aging"},{"key":"10.1016\/j.prp.2023.154481_bib15","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.18632\/aging.204071","article-title":"Comprehensive analysis of histone deacetylases genes in the prognosis and immune infiltration of glioma patients","volume":"14","author":"Shen","year":"2022","journal-title":"Aging"},{"key":"10.1016\/j.prp.2023.154481_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav4275","article-title":"Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis","volume":"5","author":"Liu","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.prp.2023.154481_bib17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s13046-020-01783-9","article-title":"HDAC2 inhibits EMT-mediated cancer metastasis by downregulating the long noncoding RNA H19 in colorectal cancer","volume":"39","author":"Hu","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.prp.2023.154481_bib18","first-page":"1027","article-title":"A novel HDAC1 inhibitor, CBUD\u20111001, exerts anticancer effects by modulating the apoptosis and EMT of colorectal cancer cells","volume":"57","author":"Kim","year":"2020","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.prp.2023.154481_bib19","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.biocel.2010.05.006","article-title":"Histone deacetylase 1 is required for transforming growth factor-beta1-induced epithelial-mesenchymal transition","volume":"42","author":"Lei","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.prp.2023.154481_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","article-title":"Chinese glioma genome atlas (CGGA): a comprehensive resource with functional genomic data from Chinese glioma patients","volume":"19","author":"Zhao","year":"2021","journal-title":"Genom. Proteom. Bioinform."},{"key":"10.1016\/j.prp.2023.154481_bib21","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2023.154481_bib22","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","article-title":"TISIDB: an integrated repository portal for tumor-immune system interactions","volume":"35","author":"Ru","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.prp.2023.154481_bib23","article-title":"Profiles of acetylation regulation genes contribute to malignant progression and have a clinical prognostic impact on liver cancer","volume":"2022","author":"Zhu","year":"2022","journal-title":"Dis. Mark."},{"key":"10.1016\/j.prp.2023.154481_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40169-020-0260-7","article-title":"EGFR-vIII downregulated H2AZK4\/7AC though the PI3K\/AKT-HDAC2 axis to regulate cell cycle progression","volume":"9","author":"Zhao","year":"2020","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.prp.2023.154481_bib25","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.149232","article-title":"Nonredundant, isoform-specific roles of HDAC1 in glioma stem cells","volume":"6","author":"Lo Cascio","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.prp.2023.154481_bib26","first-page":"154","article-title":"Histone deacetylase 1 promotes glioblastoma cell proliferation and invasion via activation of PI3K\/AKT and MEK\/ERK signaling pathways","volume":"2018","author":"Li","year":"1692","journal-title":"Brain Res."},{"key":"10.1016\/j.prp.2023.154481_bib27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/neuonc\/noz136","article-title":"NFAT2-HDAC1 signaling contributes to the malignant phenotype of glioblastoma","volume":"22","author":"Song","year":"2020","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.prp.2023.154481_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s13402-016-0301-9","article-title":"Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine","volume":"40","author":"Staberg","year":"2017","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.prp.2023.154481_bib29","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/iub.2463","article-title":"Epigenetic targeting of SLC30A3 by HDAC1 is related to the malignant phenotype of glioblastoma","volume":"73","author":"Zhang","year":"2021","journal-title":"IUBMB Life"},{"key":"10.1016\/j.prp.2023.154481_bib30","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1002\/jcp.25797","article-title":"Epithelial-mesenchymal transition (EMT): a biological process in the development, stem cell differentiation, and tumorigenesis","volume":"232","author":"Chen","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.prp.2023.154481_bib31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1387\/ijdb.210180gk","article-title":"Epithelial-to-mesenchymal transition of tumor cells: cancer progression and metastasis","volume":"66","author":"Vardas","year":"2022","journal-title":"Int. J. Dev. Biol."},{"key":"10.1016\/j.prp.2023.154481_bib32","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","article-title":"Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer","volume":"171","author":"Puram","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.prp.2023.154481_bib33","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1038\/s41598-020-65331-3","article-title":"MicroRNA-128-3p enhances the chemosensitivity of temozolomide in glioblastoma by targeting c-Met and EMT","volume":"10","author":"Zhao","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2023.154481_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158171","article-title":"Exploring the mechanism of adjuvant treatment of glioblastoma using temozolomide and metformin","volume":"23","author":"Feng","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2023.154481_bib35","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1111\/jcmm.14976","article-title":"Transcriptome analyses reveal molecular mechanisms underlying phenotypic differences among transcriptional subtypes of glioblastoma","volume":"24","author":"Pan","year":"2020","journal-title":"J. Cell. Mol. Med."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823001814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823001814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:56:41Z","timestamp":1759733801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823001814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":35,"alternative-id":["S0344033823001814"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154481","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HDAC1 mediates epithelial\u2013mesenchymal transition and promotes cancer cell invasion in glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154481","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"154481"}}